WA
IDYA icon

WPG Advisers’s IDEAYA Biosciences IDYA Stock Holding History

WPG Advisers’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.62K Buy
124
+50
+68% +$1.53K ﹤0.01% 993
2026
Q1 		$2.47K Hold
74
– – ﹤0.01% 1039
2025
Q4 		$2.56K Buy
+74
New +$2.36K ﹤0.01% 1067

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

WPG Advisers's IDYA Position: Q2 2026 in Review

WPG Advisers increased its IDEAYA Biosciences (IDYA) stake by 68% in Q2 2026, buying an estimated $1.53K and bringing the position to 124 shares worth $4.62K. The position accounts for ﹤0.01% of the portfolio, ranked #993.

WPG Advisers first reported a position in IDYA in Q4 2025 and has held it in 3 quarters since. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • WPG Advisers held 124 shares of IDEAYA Biosciences worth $4.62K as of Q2 2026.
  • WPG Advisers bought 50 IDEAYA Biosciences shares in Q2 2026, an estimated $1.53K.
  • IDEAYA Biosciences made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #993 holding.
  • WPG Advisers first reported a position in IDEAYA Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.